Design, molecular characterization and therapeutic investigation of a novel CCR8 peptide antagonist that attenuates acute liver injury by inhibiting infiltration and activation of macrophages
aPersonalized Diagnostics and Therapeutics, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology, University of Twente, the Netherlands
bInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH University Hospital Aachen, Germany
cDepartment of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, India
dDevelopmental BioEngineering, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology, University of Twente, the Netherlands
* Corresponding author.
收起